Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial)

Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial)

Abstract Background Chronic treatment of hypertension or heart failure very often includes an angiotensin-converting enzyme inhibitors (ACE-Is) or angiotensin receptor blockers (ARBs) as renin-angiotensin system inhibitors (RASi) treatments. To stop or not to stop these medications before major surg...

Full description

Bibliographic Details
Main Authors: Matthieu Legrand, Emmanuel Futier, Marc Leone, Benjamin Deniau, Alexandre Mebazaa, Benoît Plaud, Pierre Coriat, Patrick Rossignol, Eric Vicaut, Etienne Gayat, for the STOP-OR-NOT study investigators
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Trials
Subjects:
ACE inhibitors
ARB
Strategy
Outcome
Complications
Acute kidney injury
Online Access:http://link.springer.com/article/10.1186/s13063-019-3247-1

Internet

http://link.springer.com/article/10.1186/s13063-019-3247-1

Similar Items